Last reviewed · How we verify
NCT04754932
Implementation of Cognitive Stimulation Therapy
NA trial testing Cognitive Stimulation Therapy in Dementia in 23 participants. Completed in 30 September 2022.
30 September 2022
Quick facts
| Lead sponsor | Duke University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 23 |
| Start date | 27 May 2021 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Cognitive Stimulation Therapy
Conditions studied
- Dementia — all drugs for Dementia →
Sponsor
Duke University
Who can join
Eligibility, any sex, with Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to examine the feasibility of implementing Cognitive Stimulation Therapy (CST) under real world circumstances in a more heterogenous population, with the ultimate goal of making the treatment broadly accessible. The effects of CST on the behavioral and psychological symptoms of dementia (BPSD) as a non-pharmacologic intervention will also be studied.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04754932
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive Stimulation Therapy
Trials testing the same drug.
- NCT06978972 — Cognitive Stimulation Therapy for Residents With Dementia in Nursing Homes · NA · completed
- NCT06115785 — Cognitive Stimulation Therapy and Olderly People With Mild Cognitive Impairment · NA · completed
- NCT05808530 — Cognitive Stimulation Therapy · NA · completed
- NCT05514678 — Cognitive Stimulation Therapy for Dementia · NA · completed
- NCT05394584 — CST-HK for Cognition and Well-being in People With Dementia · NA · completed
Other recruiting trials for Dementia
Currently open trials in the same condition.
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
- NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
- NCT06088810 — The Impact of Music Intervention on Sleep · NA · recruiting
- NCT07482800 — Dementia in Fiction and Clinical Narratives · recruiting
- NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
Other Duke University trials
Trials by the same sponsor.
- NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
- NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
- NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
- NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
- NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04754932 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Duke University
- Last refreshed: 14 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04754932.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing